AEON Biopharma (AEON) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.24, +6.11% vs the prior close of $0.23.
- Volume 391.40K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
AEON jumps 6.1% to $0.24. Closed at $0.24, +6.11% vs the prior close of $0.23. Day range $0.23–$0.25, opened at $0.23.
AEON daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — AEON jumps 6.1% to $0.24
- Closed at $0.24, +6.11% vs the prior close of $0.23. Day range $0.23–$0.25, opened at $0.23.
- Volume was 391.40K shares, 0.0x its 50-day average of 9.54M — lighter than usual.
- Price is -7.3% vs its 50-day average ($0.26) and -66.5% vs its 200-day average ($0.72).
- 52-week range $0.18–$1.45; today's close sits at 5% of that range, 83.2% below the 52-week high.
Oct 14, 2026 — AEON dips 0.4% to $0.23, a 1-month low, 5 down days in a row
- Closed at $0.23, -0.43% vs the prior close of $0.23. Day range $0.22–$0.24, opened at $0.23.
- Volume was 1.13M shares, 0.1x its 50-day average of 9.53M — lighter than usual.
- Price is -12.9% vs its 50-day average ($0.26) and -68.6% vs its 200-day average ($0.73).
- 52-week range $0.18–$1.45; today's close sits at 4% of that range, 84.2% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — AEON slides 6.5% to $0.23, a 1-month low, 4 down days in a row
- Closed at $0.23, -6.50% vs the prior close of $0.25. Day range $0.22–$0.25, opened at $0.24.
- Volume was 1.29M shares, 0.1x its 50-day average of 9.52M — lighter than usual.
- Price is -13.0% vs its 50-day average ($0.26) and -68.6% vs its 200-day average ($0.73).
- 52-week range $0.18–$1.45; today's close sits at 4% of that range, 84.1% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — AEON slides 10.9% to $0.25, 3 down days in a row
- Closed at $0.25, -10.87% vs the prior close of $0.28. Day range $0.24–$0.28, opened at $0.27.
- Volume was 1.08M shares, 0.1x its 50-day average of 9.64M — lighter than usual.
- Price is -7.4% vs its 50-day average ($0.27) and -66.6% vs its 200-day average ($0.74).
- 52-week range $0.18–$1.45; today's close sits at 5% of that range, 83.0% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — AEON slides 11.0% to $0.28
- Closed at $0.28, -10.97% vs the prior close of $0.31. Day range $0.28–$0.32, opened at $0.31.
- Volume was 1.62M shares, 0.2x its 50-day average of 9.61M — lighter than usual.
- Price is +3.5% vs its 50-day average ($0.27) and -62.7% vs its 200-day average ($0.74).
- 52-week range $0.18–$1.45; today's close sits at 8% of that range, 81.0% below the 52-week high.
Oct 8, 2026 — AEON dips 0.3% to $0.31
- Closed at $0.31, -0.32% vs the prior close of $0.31. Day range $0.29–$0.32, opened at $0.31.
- Volume was 1.13M shares, 0.1x its 50-day average of 9.59M — lighter than usual.
- Price is +16.5% vs its 50-day average ($0.27) and -58.4% vs its 200-day average ($0.74).
- 52-week range $0.18–$1.45; today's close sits at 10% of that range, 78.6% below the 52-week high.
Oct 7, 2026 — AEON jumps 7.2% to $0.31
- Closed at $0.31, +7.24% vs the prior close of $0.29. Day range $0.28–$0.33, opened at $0.29.
- Volume was 2.92M shares, 0.3x its 50-day average of 9.54M — lighter than usual.
- Price is +17.4% vs its 50-day average ($0.26) and -58.4% vs its 200-day average ($0.75).
- 52-week range $0.18–$1.45; today's close sits at 11% of that range, 78.6% below the 52-week high.
Oct 6, 2026 — AEON jumps 7.4% to $0.29
- Closed at $0.29, +7.41% vs the prior close of $0.27. Day range $0.26–$0.29, opened at $0.26.
- Volume was 2.26M shares, 0.2x its 50-day average of 9.51M — lighter than usual.
- Price is +10.0% vs its 50-day average ($0.26) and -61.4% vs its 200-day average ($0.75).
- 52-week range $0.18–$1.45; today's close sits at 9% of that range, 80.0% below the 52-week high.
Oct 5, 2026 — AEON slides 3.2% to $0.27, 3 down days in a row
- Closed at $0.27, -3.23% vs the prior close of $0.28. Day range $0.25–$0.28, opened at $0.28.
- Volume was 1.74M shares, 0.2x its 50-day average of 9.48M — lighter than usual.
- Price is +2.6% vs its 50-day average ($0.26) and -64.3% vs its 200-day average ($0.76).
- 52-week range $0.18–$1.45; today's close sits at 7% of that range, 81.4% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — AEON slides 3.8% to $0.28
- Closed at $0.28, -3.79% vs the prior close of $0.29. Day range $0.26–$0.30, opened at $0.30.
- Volume was 3.23M shares, 0.3x its 50-day average of 9.42M — lighter than usual.
- Price is +6.2% vs its 50-day average ($0.26) and -63.2% vs its 200-day average ($0.76).
- 52-week range $0.18–$1.45; today's close sits at 8% of that range, 80.8% below the 52-week high.
AEON latest news & SEC filings
Every SEC filing by or about AEON in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Sep 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 21, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lynch Timothy P bought 1,150,000 shares at $0.21 (≈$241.50K) on Aug 19, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 21, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$1.16M (prior year -$6.64M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.02 (prior year -$0.60) (loss narrowed vs Jun 30, 2025)
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Jul 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 21, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 8.01 — Reported other events the company considers important.
Jul 15, 2026 · Form 424B4 — Final prospectus with offering price
Final prospectus with offering price
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 13, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Jul 13, 2026 · Form S-1MEF — S-1MEF filing
S-1MEF filing
Jul 9, 2026 · Form S-1/A — S-1/A filing
S-1/A filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade AEON
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 30, 2026, Nov 14, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.53% (largest 15.8%). That is a volatile stock.
- Liquidity: about 7.28M shares (≈$1.77M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.24 vs a range of $0.18–$1.45 (5% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:72 on Feb 26, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 1 open-market buys, 0 sales; latest: Timothy P Lynch bought 1,150,000 shares on Aug 19, 2026.
- Latest filings: 8-K Sep 30, 2026; 10-Q Aug 12, 2026; 8-K Aug 12, 2026.
- Share count: 49.88M shares outstanding (Aug 6, 2026), +4184.1% vs a year earlier — notable dilution.
- Listing: NYSE · industry: Pharmaceutical Preparations.
AEON market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.23 | 0.25 | 0.23 | 0.24 | 391.40K |
| Oct 14, 2026 | 0.23 | 0.24 | 0.22 | 0.23 | 1.13M |
| Oct 13, 2026 | 0.24 | 0.25 | 0.22 | 0.23 | 1.29M |
| Oct 12, 2026 | 0.27 | 0.28 | 0.24 | 0.25 | 1.08M |
| Oct 9, 2026 | 0.31 | 0.32 | 0.28 | 0.28 | 1.62M |
| Oct 8, 2026 | 0.31 | 0.32 | 0.29 | 0.31 | 1.13M |
| Oct 7, 2026 | 0.29 | 0.33 | 0.28 | 0.31 | 2.92M |
| Oct 6, 2026 | 0.26 | 0.29 | 0.26 | 0.29 | 2.26M |
| Oct 5, 2026 | 0.28 | 0.28 | 0.25 | 0.27 | 1.74M |
| Oct 2, 2026 | 0.30 | 0.30 | 0.26 | 0.28 | 3.23M |
| Oct 1, 2026 | 0.30 | 0.33 | 0.28 | 0.29 | 6.64M |
| Sep 30, 2026 | 0.32 | 0.42 | 0.24 | 0.30 | 116.17M |
| Sep 29, 2026 | 0.26 | 0.26 | 0.25 | 0.26 | 194.90K |
| Sep 28, 2026 | 0.26 | 0.27 | 0.26 | 0.26 | 310.70K |
| Sep 25, 2026 | 0.26 | 0.27 | 0.26 | 0.26 | 565.20K |
| Sep 24, 2026 | 0.26 | 0.27 | 0.25 | 0.26 | 561.70K |
| Sep 23, 2026 | 0.27 | 0.28 | 0.26 | 0.26 | 1.28M |
| Sep 22, 2026 | 0.26 | 0.26 | 0.25 | 0.26 | 398.50K |
| Sep 21, 2026 | 0.25 | 0.26 | 0.24 | 0.25 | 661.80K |
| Sep 18, 2026 | 0.25 | 0.27 | 0.24 | 0.24 | 2.09M |
About AEON Biopharma
AEON Biopharma (AEON) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in ALISO VIEJO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1837607.
AEON board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Robert E. Bancroft | PRESIDENT & CEO | Feb 19, 2026 |
| Eric G Carter | Director | Jun 22, 2026 |
| Jost Fischer | Director | Jun 22, 2026 |
| Marc Forth | Director | Jun 22, 2026 |
| Robert J Palmisano | Director | Jun 22, 2026 |
| Shelley B Thunen | Director | Jun 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Robert E. Bancroft | PRESIDENT & CEO | Feb 19, 2026 |
| John Bencich | CHIEF FINANCIAL OFFICER | Apr 3, 2026 |
| Chad Oh | CHIEF MEDICAL OFFICER | Mar 11, 2026 |
| Jennifer Sy | PRINCIPAL ACCOUNTING OFFICER | Mar 5, 2026 |
| Alexander Blair Wilson | CLO, CSO, and Corp Secretary | Mar 5, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 19, 2026 | Timothy P Lynch | Buy | 1,150,000 | $0.21 |
AEON financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-39.22M | -3.95 | $-17.31M |
| Dec 31, 2024 | — | $42.01M | 72.93 | $-20.29M |
| Dec 31, 2022 | — | $-52.56M | -0.38 | $-35.58M |
| Dec 31, 2021 | — | $8.20M | — | $-1.49M |
Latest balance sheet: total assets $5.91M, total liabilities $21.27M, cash $3.43M (as of Jun 30, 2026).
AEON earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $0.28 |
| May 14, 2026 | 8-K Item 2.02 (results) | $0.80 |
| Mar 30, 2026 | 8-K Item 2.02 (results) | $0.99 |
| Nov 14, 2025 | 8-K Item 2.02 (results) | $0.90 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $0.69 |
| May 14, 2025 | 8-K Item 2.02 (results) | $0.50 |
| Mar 24, 2025 | 8-K Item 2.02 (results) | $0.72 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $49.68 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Mar 29, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on AEON
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.